| Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621) |
|---|
| 01/13/2004 | US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis |
| 01/13/2004 | US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 01/13/2004 | US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6677369 Antithrombotic agents |
| 01/13/2004 | US6677360 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 01/13/2004 | US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | CA2053359C Heteroaroyl derivatives of monocyclic beta-lactam antibiotics |
| 01/08/2004 | WO2004002943A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives |
| 01/08/2004 | WO2004002939A2 Aminoalcohol derivatives |
| 01/08/2004 | WO2003093302A3 Process for the synthesis of peptides amides by side-chain attachement to a solid phase |
| 01/08/2004 | WO2002079148A3 Multifunctional carbonates and derivatives |
| 01/08/2004 | US20040006238 As chemical intermediates for production of pharmacologically useful oxazolidinones |
| 01/08/2004 | US20040006143 Aminoalcohol derivatives |
| 01/08/2004 | US20040006132 For therapy |
| 01/08/2004 | CA2492065A1 Aminoalcohol derivatives_as b3 adrenergic receptor agonist |
| 01/07/2004 | EP1378573A1 Interleukin 1 beta protease and interleukin 1 beta protease inhibitors |
| 01/07/2004 | EP1377593A2 2-amino-propanol derivatives |
| 01/07/2004 | EP1377295A2 Carboxamide derivatives as therapeutic agents |
| 01/07/2004 | EP0600880B1 Interleukin 1- beta protease and interleukin 1-beta protease inhibitors |
| 01/07/2004 | CN1466568A Preparation of hydroxyalkylcarbamates from six-membered cyclic carbonates |
| 01/07/2004 | CN1466561A Process for the preparation of a chloroketones |
| 01/07/2004 | CN1133620C Alpha, alpha'-diamino alcohol and preparation process thereof |
| 01/06/2004 | US6673958 Multifunctional dentin bonding agent |
| 01/06/2004 | CA2301990C New substitute dimerized derivatives, process for preparing them, and pharmaceutical compounds containing them |
| 01/02/2004 | EP1375474A2 Intermediate for the preparation of carvedilol |
| 01/02/2004 | EP1375463A1 Optically active compound and photosensitive resin composition |
| 01/02/2004 | EP1373195A2 Quaternary amino acids on solid supports |
| 01/02/2004 | EP1373185A2 Hydrophobic polyamine analogs and methods for their use |
| 01/02/2004 | EP1372632A1 Proliferative activator receptor (ppar) compounds |
| 01/02/2004 | EP1372390A2 Alkylamine derivatives as antifouling agents |
| 01/02/2004 | EP1175394B1 N-alkoxy-n-phenylcarbamate derivatives |
| 01/02/2004 | EP1140799B1 Novel propargylether derivatives |
| 01/01/2004 | US20040002506 Antiproliferative agents; antitumor agents |
| 01/01/2004 | US20040002491 Melatonergic receptors |
| 01/01/2004 | US20040002490 Melatonergic receptors |
| 01/01/2004 | US20040002480 Aminobutyric acid derivatives and pharmaceutical composition containing the same as active ingredient |
| 01/01/2004 | US20040002478 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase |
| 12/31/2003 | WO2004001055A2 Pna prodrugs |
| 12/31/2003 | WO2004000794A1 Multifunctional allyl carbamates and coatings therefrom |
| 12/31/2003 | WO2004000215A2 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs |
| 12/31/2003 | WO2003072055A3 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors |
| 12/31/2003 | CN1132807C Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds |
| 12/30/2003 | US6670499 Adamantane derivatives and processes for the preparation thereof |
| 12/30/2003 | US6670400 Secretion inhibitors for gastric acid, antiemetics; N(4-(2-(2-methoxyphenoxy)ethyl)aminobutyl)benzamide; |
| 12/30/2003 | US6670393 Carbamate-based cationic lipids |
| 12/30/2003 | US6670332 Cytofectins comprising complex amphiphilic lipids in which a bioactive agent which is recognized by biological systems is joined to a Rosenthal Inhibitor core structure through an alkyl linking group |
| 12/30/2003 | CA2051399C Therapeutically useful 2-aminotetralin derivatives |
| 12/25/2003 | US20030236297 Immunosuppressants; autoimmune diseases |
| 12/25/2003 | US20030236286 Central nervous system disorders; cardiovascular disorders; antiischemic agents; psychological disorders |
| 12/25/2003 | US20030236269 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 12/25/2003 | US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins |
| 12/25/2003 | US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/25/2003 | US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/25/2003 | US20030235612 Compounds and compositions for delivering active agents |
| 12/24/2003 | WO2003106405A1 Aspartyl protease inhibitors |
| 12/24/2003 | WO2003106399A2 PROCESS FOR PREPARING N-PROTECTED beta-AMINO ALDEHYDE COMPOUNDS |
| 12/24/2003 | CA2489095A1 Aspartyl protease inhibitors |
| 12/23/2003 | US6667422 Process for the preparation of α-haloketones |
| 12/23/2003 | US6667414 Renin inhibitors; hypertensive agents |
| 12/23/2003 | US6667413 Uracil compounds and use thereof |
| 12/23/2003 | US6667404 Retroviral protease inhibiting compounds |
| 12/18/2003 | WO2003104184A1 Methods for synthesis of acyloxyalkyl derivatives of gaba analogs |
| 12/18/2003 | WO2003104167A2 Cyanohydrin ethers and esters as high-sensitivity enzyme substrates |
| 12/18/2003 | WO2003103722A1 New agents for magnetic imaging method |
| 12/18/2003 | WO2003072537A3 Selective protein tyrosine phosphatatase inhibitors |
| 12/18/2003 | WO2003070701B1 Syntheses of quinazolinones |
| 12/18/2003 | WO2003024401A3 Piperizinones as modulators of chemokine receptor activity |
| 12/18/2003 | WO2002083030A3 Bifunctional energy-reversible acyl-compositions |
| 12/18/2003 | US20030233010 Reacting with ozone, or sodium periodate, cleaving a carbon-carbon double bond, acetalization; forming a synthetic intermediates for preparing glycopeptide antibiotics |
| 12/18/2003 | US20030232868 Cyclic carboxylic acids as integrin antagonists |
| 12/18/2003 | US20030232811 Anthranilic acid derivative |
| 12/18/2003 | US20030232786 For prevention and/or treatment of cancer, Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotropic lateral sclerosis, rheumatoid arthritis, inflammatory bowel disease |
| 12/17/2003 | EP1370520A1 Aryl and biaryl compounds having mch modulatory activity |
| 12/17/2003 | EP1370519A1 Synthetic excitatory amino acids |
| 12/17/2003 | EP1370518A2 Tryptase-inhibitors |
| 12/16/2003 | US6664412 Method for producing lysine derivative |
| 12/16/2003 | US6664410 Solid phase nitrile synthesis |
| 12/16/2003 | CA2195125C Difluorostatone antiviral agents |
| 12/11/2003 | WO2003102045A1 Hybrid polymer materials for liquid crystal alignment layers |
| 12/11/2003 | WO2003101917A2 A process for the preparation of phenylcarbamates |
| 12/11/2003 | WO2002008174A8 Phenylethylamine derivatives and their use in the treatment of melanoma |
| 12/11/2003 | US20030229201 Method comprising introducing one type or two or more types of a functional molecule post-synthetically following introduction of a precursor monomer unit into a peptide nucleic acid oligomer |
| 12/11/2003 | US20030229132 Small molecule modulators of apoptosis |
| 12/11/2003 | US20030229086 Central nervous system disorders; side effect reduction |
| 12/10/2003 | EP1369134A1 New agents for magnetic imaging method |
| 12/10/2003 | EP1368311A1 Delta1 -pyrrolines used in pest control |
| 12/10/2003 | EP1368304A1 Prodrugs of excitatory amino acids |
| 12/10/2003 | EP1368020A2 Method for identifying maxi-k channel blockers |
| 12/10/2003 | EP0971885B1 Process for preparing indane-like compounds |
| 12/10/2003 | EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS |
| 12/10/2003 | CN1461298A Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins |
| 12/09/2003 | US6660879 Use of the compound in clinical conditions associated with insulin resistance. |
| 12/09/2003 | US6660742 Alkylation therapy; anticancer agent |
| 12/04/2003 | WO2003099338A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 12/04/2003 | WO2003099192A2 Bis-aromatic alkanols |
| 12/04/2003 | WO2003057169A3 4-dedimethylamino tetracycline compounds |
| 12/04/2003 | WO2003034989A3 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE |
| 12/04/2003 | WO2002088069A9 Compounds useful as intermediates for 4-aminoquinoline derivatives |
| 12/04/2003 | WO2002083626A3 Alkyl and/or alkenyl glycerol carbamates |
| 12/04/2003 | US20030225285 Oxidizing a protected aminoalcohol to a chiral protected aminoaldehyde and diastereoselectively forming the aminoepoxide from said aminoaldehyde with an organometallic methylene-adding reagent in an appropriate solvent |